Trademarkia Logo

Canada

C$
DOSEASSURE
REGISTERED

on 22 Nov 2024

Last Applicant/ Owned by

Laboratory Corporation of America Holdings

531 South Spring StreetBurlington, NC 27215

US

Serial Number

1956644 filed on 10th Apr 2019

Registration Number

TMA1271798 registered on 22nd Nov 2024

Registration expiry Date

22nd Nov 2034

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

DOSEASSURE

Trademark usage description

scientific research for medical purposes in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation Read More

Classification Information


Class [042]
Scientific research for medical purposes in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical research; health care laboratories for conducting research in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical research laboratory services


Classification kind code

11

Class [044]
Medical services in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical testing; health care services in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; health care testing and diagnosis; health care evaluation services; health care analysis relating to the medical treatment of persons; managed health care services in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; health care clinics; health care counseling; providing health care information to patients, patient advocates and health care professionals by telephone, and global and non-global computer networks in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; providing health information to patients, patient advocates and health care professionals in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical care in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical testing and diagnosis; medical evaluation services; medical analysis services relating to the medical treatment of persons diagnosed with diseases associated with dysregulation of the immune system and immune mediated diseases; managed medical care services in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases; medical services clinics; medical counseling; providing medical information to patients, patient advocates and health care professionals in the field of biological therapy for the prevention and treatment of diseases associated with dysregulation of the immune system and immune mediated diseases


Classification kind code

11

Mark Details


Serial Number

1956644

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 26th Jun 2024
Advertised
Submitted for opposition 26
on 28th May 2024
Approved
Submitted for opposition 27
on 28th May 2024
Approval Notice Sent
Submitted for opposition 48
on 23rd Feb 2024
Agent Changed
Submitted for opposition 22
on 31st Aug 2023
Search Recorded
Submitted for opposition 20
on 31st Aug 2023
Examiner's First Report
Submitted for opposition 287
on 24th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 15th Apr 2019
Formalized
Submitted for opposition 1
on 11th Apr 2019
Created
Submitted for opposition 30
on 10th Apr 2019
Filed